Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Rev Neurol (Paris) ; 167(1): 35-8, 2011 Jan.
Artigo em Francês | MEDLINE | ID: mdl-20561657

RESUMO

INTRODUCTION: Central nervous system involvement is rare in Wegener granulomatosis. Stroke is the most common event suggestive of the disease. COMMENT: A 35-year-old woman, who was followed for rhinitis and mild asthma, described gradual decline of visual acuity in the right eye over two months, persistent nasal obstruction and fronto-orbital headache since a few weeks. She presented left hemiparesis due to a stroke, associated with exophthalmos and deficits of the optic nerve and abducens of the right eye. The otolaryngological examination found signs of crusty rhinitis and right nasal stenosis. The diagnosis of Wegener's granulomatosis was established on the basis of the clinical findings, radiological aspects and the presence of ANCA. The patient was treated by antiplatelet agents and high-dose corticosteroids associated with immunosuppressive drugs including cyclophosphamide in a monthly bolus. DISCUSSION: This case illustrates two of the three pathogenic mechanisms that may account for central nervous system involvement in Wegener granulomatosis: vasculitis, extension by contiguity of granulomatous tissue from the nasal cavity or sinuses, and in situ formation of a granuloma into the brain parenchyma or meninges.


Assuntos
Isquemia Encefálica/etiologia , Granulomatose com Poliangiite/diagnóstico , Doenças do Nervo Abducente/etiologia , Adulto , Anticorpos Anticitoplasma de Neutrófilos/sangue , Córtex Cerebral/irrigação sanguínea , Corpo Estriado/irrigação sanguínea , Ciclofosfamida/uso terapêutico , Exoftalmia/etiologia , Feminino , Granulomatose com Poliangiite/complicações , Granulomatose com Poliangiite/tratamento farmacológico , Granulomatose com Poliangiite/imunologia , Humanos , Imunossupressores/uso terapêutico , Imageamento por Ressonância Magnética , Metilprednisolona/uso terapêutico , Obstrução Nasal/etiologia , Síndromes de Compressão Nervosa/etiologia , Doenças do Nervo Óptico/etiologia , Paresia/etiologia
2.
Rev Neurol (Paris) ; 166(2): 253-6, 2010 Feb.
Artigo em Francês | MEDLINE | ID: mdl-19497602

RESUMO

INTRODUCTION: Horton's disease is the most common vasculitis of elder people. Several neurological complications are reported, but pachymeningitis is exceptional. OBSERVATION: A 71-year-old patient who presented headache, hyperesthesia of the scalp, weight loss with a biological inflammatory syndrome and meningeal thickening on MRI. The diagnosis of pachymeningitis related to Horton's disease was retained. The patient was treated by corticosteroids with a good clinical, biological and radiological course after 22 months. CONCLUSION: Horton's disease is a potential diagnosis in elderly persons with pachymeningitis and inflammatory syndrome.


Assuntos
Corticosteroides/uso terapêutico , Arterite de Células Gigantes/complicações , Idoso , Dura-Máter/patologia , Feminino , Arterite de Células Gigantes/tratamento farmacológico , Cefaleia/etiologia , Humanos , Hiperestesia/tratamento farmacológico , Hiperestesia/etiologia , Inflamação/patologia , Imageamento por Ressonância Magnética , Meninges/anatomia & histologia , Meninges/efeitos dos fármacos , Meninges/patologia , Meningite/etiologia , Couro Cabeludo/fisiopatologia
3.
Rev Neurol (Paris) ; 165(12): 1103-6, 2009 Dec.
Artigo em Francês | MEDLINE | ID: mdl-19541334

RESUMO

INTRODUCTION: Neurological manifestations of celiac disease are rare and polymorphic. Similar to lesions of the digestive tract, the standard treatment includes steroids. CASE REPORT: A 41-year-old woman, followed up for celiac disease resistant to gluten-free diet, developed rapidly spastic paraparesis, cerebellar syndrome, horizontal diplopia and decline of visual acuity. The diagnosis of neurological complications of celiac disease was established and the patient was treated with methylprednisolone, followed by oral prednisone. For 9 years, the patient's neurological status remained stabilized with a prednisone dose at 20mg per day. The patient relapsed when progressive reduction of prednisone dose was attempted; neurological and gastrointestinal signs worsening at 15mg per day; increasing the dose to 30mg improved the clinical status. DISCUSSION: The mechanism of onset of neurological disease remains unknown. Immunological, nutritional, toxic or metabolic factors could be involved. The positive response to corticosteroids observed in this patient suggest an immunological mechanism.


Assuntos
Corticosteroides/uso terapêutico , Doença Celíaca/complicações , Doença Celíaca/tratamento farmacológico , Doenças do Sistema Nervoso/diagnóstico , Prednisona/uso terapêutico , Adulto , Diarreia/etiologia , Diplopia/etiologia , Feminino , Humanos , Doenças do Sistema Nervoso/tratamento farmacológico , Doenças do Sistema Nervoso/etiologia , Transtornos da Visão/etiologia , Acuidade Visual
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA